Circulating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS) - Wikidata - thesis-toulmin - TriplyDB

Circulating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS)

Circulating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS)

http://www.wikidata.org/entity/Q33765348

about

Almanac 2015: atrial fibrillation research in Heart Influence of ACE I/D Polymorphism on Circulating Levels of Plasminogen Activator Inhibitor 1, D-Dimer, Ultrasensitive C-Reactive Protein and Transforming Growth Factor β1 in Patients Undergoing Hemodialysis Association of Plasma Transforming Growth Factor-β1 Levels and the Risk of Atrial Fibrillation: A Meta-Analysis Relaxin Level in Patients With Atrial Fibrillation and Association with Heart Failure Occurrence: A STROBE Compliant Article.Inflammation and the pathogenesis of atrial fibrillation.Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation.Potential Biological Markers of Atrial Fibrillation: A Chance to Prevent Cryptogenic Stroke Longitudinal relationships of periodic limb movements during sleep and incident atrial fibrillation.Chronotropic Incompetence and Risk of Atrial Fibrillation: The Henry Ford ExercIse Testing (FIT) Project.CHA2DS2-VASc score and blood biomarkers to identify patients with atrial high rate episodes and paroxysmal atrial fibrillation: the role of TIMP-4 regulation.Serum Androgens and Risk of Atrial Fibrillation in Older Men: The Cardiovascular Health Study.Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications.

P2860

Q26770598-A148B244-E425-43EA-B7EE-0022DCFF710B Q35972437-76AC24F4-9706-40BC-A69A-BF8AE262C6EA Q36015700-D0C4B816-68CB-49B3-8769-E42DC973CF53 Q36992872-5FE694AE-B50F-4C9E-AB52-5FA1FE624E69 Q38333088-4C209354-1157-4224-BDD3-D41D28752D1F Q38878811-A535097E-2B3E-4ED5-9932-9F7B4E57CDCB Q41146607-FDCFC20A-8193-4FD2-BA31-FABEC8D74B94 Q42362275-A412243A-9730-4D71-BFF6-F81EA457C173 Q43109711-061E232B-D884-4F34-9FBA-3E9AA13F9C60 Q50089311-80B001EF-245E-4CA4-ABCB-F0CC4E8BCFB1 Q52315820-471B2BA9-715C-4F5D-85CC-86EB22B35EB9 Q52340243-C32E6BA7-EA13-44EA-98EC-158423327867

P2860

Circulating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS)

http://www.wikidata.org/entity/Q33765348

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Circulating fibrosis biomarker ...... diovascular Health Study (CHS)

@ast

Circulating fibrosis biomarker ...... diovascular Health Study (CHS)

@en

type

label

Circulating fibrosis biomarker ...... diovascular Health Study (CHS)

@ast

Circulating fibrosis biomarker ...... diovascular Health Study (CHS)

@en

prefLabel

Circulating fibrosis biomarker ...... diovascular Health Study (CHS)

@ast

Circulating fibrosis biomarker ...... diovascular Health Study (CHS)

@en

P1433

Q33765348-885591EE-9FC0-4E3F-AB89-825DAC81A47F

P1476

Q33765348-73A4FBC8-E8DF-4443-8DE9-2DAF847435FC

P2093

Q33765348-32BE86E0-EF80-4065-B647-631EB75FB698

Q33765348-33D4A923-9275-4B6A-A508-0927013EF94A

Q33765348-5DE61BED-1E99-41AD-9127-186BCEBBEA45

Q33765348-73E689EA-38EB-4F2D-9157-BD845491732A

Q33765348-BD36E60C-2E3B-4CD1-8760-6E2A9A7BF3D4

Q33765348-C5DF4B83-C160-451D-BF55-77B57FE5A7D9

Q33765348-CED0D16E-E4D0-4EC7-BDEE-7F889118AA61

Q33765348-E16EA254-51A4-40F8-8857-849ABEDAE259

P2860

Q33765348-08B92C0A-3C58-4152-AE97-2D5D81B7ADEB

Q33765348-0A51755C-D739-439A-9952-06B06B9EE1D4

Q33765348-0C464D91-A581-4843-8DB5-86277C620435

Q33765348-14E7AF88-87E6-40F6-B999-10837E1CF04E

Q33765348-22195855-B442-42AC-BCEB-9444BD39C6E7

Q33765348-28D41C90-0203-45E4-A501-85D7E8B4D472

Q33765348-29C34E93-7091-45D1-B1A3-BDA2CED29DE6

Q33765348-331060A5-7878-4B4E-B283-EB024AB2AB48

Q33765348-36FA64BF-8E20-4EDF-BAE8-505DA1BF6493

Q33765348-4B71794F-94BF-42CC-BB5C-C6405C0AA9D3

P304

Q33765348-04506F9F-12C0-4F17-996F-5555972A70B5

P31

Q33765348-0C868CA2-541C-4722-8283-E390F999CF0D

P356

Q33765348-5763C6F0-909A-4CA8-B7DE-4343084CB809

P407

Q33765348-BCD739B5-8242-4EB2-8332-B7DEF0436C4A

P433

Q33765348-AC81D832-4754-4361-B819-3FE5CC13C3ED

P478

Q33765348-EFD184AD-DA96-4F10-B613-3AE4B8BA47B3

P50

Q33765348-438649FC-AC87-4DE3-A679-21DBAFEC1476

Q33765348-49D28644-7AF5-4F3B-B30C-9C598AC65A04

Q33765348-C1E63FC4-053A-4BFF-9FA7-E2A8097F9906

P577

Q33765348-441335E9-7C52-4FC4-A174-FA14D17242C8

P698

Q33765348-AEECE9D7-8AAB-473D-817A-55502367DFE3

P921

Q33765348-0FFCBE9B-0139-44EE-A3CD-9E979F9ECE8F

P932

Q33765348-4A6EE59A-79B2-48C6-BB5B-E1E97A03FC8E

P356

J.AHJ.2014.01.010

P1433

American Heart Journal

P1476

Circulating fibrosis biomarker ...... diovascular Health Study (CHS)

@en

P2093

Alex Y Tan

http://www.w3.org/2001/XMLSchema#string

Jorge R Kizer

http://www.w3.org/2001/XMLSchema#string

Kenneth J Mukamal

http://www.w3.org/2001/XMLSchema#string

Luc Djousse

http://www.w3.org/2001/XMLSchema#string

Marlena Maziarz

http://www.w3.org/2001/XMLSchema#string

Michael A Rosenberg

http://www.w3.org/2001/XMLSchema#string

Nicole L Glazer

http://www.w3.org/2001/XMLSchema#string

Susan J Zieman

http://www.w3.org/2001/XMLSchema#string

P2860

The Cardiovascular Health Study: design and rationale

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

Fish intake and risk of incident atrial fibrillation.

N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study.

Transforming growth factor beta-1 and incidence of heart failure in older adults: the Cardiovascular Health Study.

Relations of biomarkers of extracellular matrix remodeling to incident cardiovascular events and mortality.

Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study

Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.

Creatinine-or cystatin C-based equations to estimate glomerular filtration in the general population: impact on the epidemiology of chronic kidney disease.

The origin of fibroblasts and mechanism of cardiac fibrosis

P304

723-8.e2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AHJ.2014.01.010

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

167

http://www.w3.org/2001/XMLSchema#string

P50

David S Siscovick

Susan R Heckbert

P577

2014-02-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24766983

http://www.w3.org/2001/XMLSchema#string

P921

P932

4060155

http://www.w3.org/2001/XMLSchema#string